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Abstracts: Psoriasis is an immune mediated chronic inflammatory disorder. Psoriasis treatment regimen is an immune 
regulation and inhibition of the cell cycle to prevent hyper proliferation of keratinocytes. Psoriasis does not affect the 
reproductive ability of patients; however, psoriatic women in reproductive period should be aware of the side effects of 
psoriatic medication. Understanding the molecular mechanisms beyond Psoriasis is crucial in developing effective 
treatment options for Psoriasis and preventing birth defects such as spontaneous abortions, intermittent fetal 
bradycardia, malformations and miscarriages.  
Vitamin A and vitamin D are the skin hormones that regulate the cell cycle of the keratinocytes. Vitamin A and D 
deliveries are extensively used in psoriasis treatment. Vitamin A is important for neuronal development; however, 
excessive use of vitamin A is teratogenic. Vitamin D is useful for Psoriasis treatment and is required for bone integrity. 
Vitamin D is also important for women’s fertility. Both vitamin A and vitamin D play a pleiotropic role in metabolism by 
regulating different gene expressions. Thus, the use of the vitamins or their derivatives in psoriasis treatment is vital for 
the fetus development. In this review we focus on the vitamin A and D metabolism, particularly molecular and genetic 
aspects of psoriasis treatment during pregnancy. 
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INTRODUCTION 
Psoriasis is a hyper-proliferative, relapsing 
inflammatory dermatosis with strong genetic 
susceptibility and multifactorial etiology [1]. 
Pathogenesis of Psoriasis is still unclear; however, the 
gene knock-in and knock-out studies are helpful in 
clarifying pathogenesis of psoriasis [2]. Several 
genome and epigenome wide association studies have 
focused on dozens of genes in their attempts to find out 
the immune mediated mechanisms of psoriasis [3-5]. 
Understanding the molecular mechanisms beyond 
psoriasis is crucial for the development of the effective 
treatment options of the disease. Psoriasis never 
affects the fertility of patients; however, psoriatic 
women in childbearing period must be aware of the 
side effects the medication has on a fetal growth. 
Histologically, psoriasis is defined as an abnormal 
differentiation and proliferation of keratinocytes, 
infiltration of the T cells, dendritic cells, macrophages, 
neutrophils and neoangiogenesis. Keratinocytes are 
the specialized epithelial cells that undergo a well-
defined differentiation cycle. Keratinocytes turnover 
from stem cells to mature keratinocyte takes 13 days; 
however, in psoriatic patients the turnover time of 
epidermal keratinocytes is shorter, between 1  
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and 3 days [6]. Proliferation of the keratinocyte occurs 
at the bottom of the stratum basal and during the 
differentiation process the keratiocytes move up to 
stratum corneum. From the molecular standpoint, the 
differentiation of the keratinocytes depends on several 
factors, such as level of calcium, vitamin A and vitamin 
D [7-11]. The concentration of the calcium, vitamin A 
and vitamin D vary in different layers. Calcium ions 
gradient is important for keratinocyte proliferation and 
differentiation of keratinocytes [11-12]. Furthermore, 
calcium concentration plays a major role in 
differentiation as well as migration of keratinocytes. 
Vitamin A and D are accepted as skin hormones 
because of the role they play in growth, differentiation 
and reproduction of skin cells by regulating gene 
expression [14, 15]. Vitamin D is an important regulator 
because of its ligand modulated transcription activity in 
steroid, thyroid, and retinoic acid genes [13]. 
Vitamin A Metabolism and Skin Homeostasis 
Vitamin A is a fat soluble molecule that has a 
function in metabolic and physiologic activities. Animal 
fats (especially fish oil), yellow and green vegetables 
are the major sources of vitamin A. The body takes 
75% of its vitamin A needs from retinyl esters (egg, 
liver, milk etc) and 25% from carotenoid (vegetables). 
Digested Vitamin A is transported to enterocytes by 
chylomicron transport, and then to hepatocytes through 
the lymphatic system. Digested retinyl esters are stored 
in the liver until they are released into the blood 
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circulation system. Retinol, the hydrolyzed form of 
retinyl esters, is a molecule with low solubility and 
chemical stability in aqueous solutions; thus, retinol 
requires binding to retinol-binding protein (RBP). The 
cellular import of retinol-RBP complex occurs in 
specific transmembrane receptors (stimulated by 
retinoic acid –STRA6). 
Retinoids (vitamin A and its derivatives) play an 
important role in transforming immature keratinocytes 
to mature form [16]. Retinoids represent its biologic 
function by binding to nuclear retinoic acid receptors 
(RAR) and retinoid-X-receptors (RXR). Retinoid 
mediated gene transcription are activated through 
binding of the RAR/RXR heterodimers or RXR/RXR 
homodimers complexes to retinoic acid responsive 
elements (RARE) in promotor region of the target 
genes; thus, this affects gene expression level upon 
ligand binding [17].  
Previous studies have confirmed that synthetic 
trans-retinoic acid analogs decrease the expression of 
keratins 5, 6, 14, and 17 and increase the expression 
of keratins 13 and 19 [18]. Retinoids are widely used in 
dermatopharmacology because of their regulatory role 
in keratinocyte proliferation, epidermal differentiation 
and keratinization [8, 19]. Etretinate (Tigason, Tegison) 
and its active metabolite acitretin (Neotigason, 
Soriatane) are the retinoid acid derivatives that are 
used in dermatopharmacology.  
Vitamin A and Management of Pregnancy in 
Psoriatic Women 
Previous studies have shown that acitretin regulates 
T-helper (Th)1 and Th17 cells, which makes this and 
effective treatment in psoriasis. [20-21]. Psoriatic 
epidermal hyperplasia is a result of an imbalanced 
Th1/Th2 differentiation ratio. Psoriasis is a Th1 
dominant condition, however, during pregnancy a 
temporarily switch to a Th2 system occurs and this 
prevents Th1 response; as a result, psoriasis improves 
during pregnancy [22]. Acitretin is an oral retinoid, 
which has various side effects, such as teratogenicity, 
cheilitis, xerosis, dyslipidemia, and photosensitivity 
[23]. Fetal abnormalities that occur due to oral use of 
retinoids include craniofacial, musculoskeletal and 
central nervous system anomalies [24-25]. Topical 
medications and phototherapy should be preferred 
instead of retinoids for female psoriatic patients with 
reproductive potential. 
Patients with resistant skin psoriasis require 
systemic treatments, such as cyclosporine A, 
methotrexate, retinoids and biologic agents. Because 
of the more effective pharmacokinetic profile Acitretin is 
preferred even if patients are not responsive to other 
therapies [22, 26-28]. The previous report has shown 
that etretinate causes spontaneous abortions 2.75 and 
3.2 years after discontinued use of medication. 
However, no complication occurred in women or babies 
1, 3 and 5 years later after discontinued use of 
 
*RBP (retinol binding proteins). STRA6 (stimulated by retinoic acid 6). CRBP (cellular retinol binding proteins). ADH (alcohol dehydrogenases). RDH (retinol 
dehydrogenases). RALDH (retinaldehyde dehydrogenases). RA (retinoic acid). CRABP (cellular retinoic acid binding proteins). RAR (retinoic acid receptors). RXR 
(retinoid X receptors). RARE (retinoic acid response element).  
Figure 1: An overview of the retinoic acid pathway is represented. 
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etretinate [29]. Nijhof et al. [30] have shown that use of 
acitretin caused intermittent fetal bradycardia. The 
overdose of retinoic acid intake increased the risk of 
miscarriage. Thus, dermatologists should be 
performing pregnancy tests before applying acitretin 
treatment. Also, oral contraceptive drugs must be used 
along with acitretin. The predominant view is that 
pregnancy should be planned 2 years after 
discontinued use of acitretin [25]. 
The retinoic acids are required to arrange patterning 
and differentiation of neural development. However, an 
overdose of retinoic acid causes anomalies, such as 
neural tube defect(NTD) because of its effects on 
retinoic acid signaling and chromatin structure 
remodeling [31, 32]. Retinoic acids (RA) and thyroid 
hormones (TH) share common receptors (RXR) and 
bind to hormone-response elements (HREs); thus, 
there is a cross-talk between these hormone molecules 
[32]. The recent experiment has shown that the mouse 
fetuses that were exposed to an overdose of RA 
ectopically suppress TH signaling and spinal NTDs 
[32]. Retinoic signaling pathway is capable of changing 
cellular membrane permeability in human 
keratinocytes, as well as in amniotic environment, by 
regulating aquaporin (AQP) gene expressions [33-34]. 
All-trans retinoic acid have effects on trans-membrane 
flow of water and glycerol; thus, limitation of retinoic 
acid use is important in preventing adiposity and insulin 
resistance in fetus because of its secondary effect on 
fetal glucose and energy metabolisms [34-35]. 
There is also an increased risk of miscarriage. 
Therefore, psoriatic women in childbearing age should 
be informed about teratogenic effects of acitretin before 
the treatment is applied [36, 37]. The psoriatic women 
who use acitretin for psoriasis treatment must be 
informed before and during gestation period.  
Vitamin D Metabolism and Skin Homeostasis 
Bioactive form of vitamin D (1,25-
dihydroxycholecalciferol) is a steroid hormone that has 
a pleiotropic role in metabolism by regulating different 
gene expression [9, 38]. Vitamin D production and 
catabolism occurs only in keratinocytes. Vitamin D is 
synthesized as a prohormone (7-dehydrocholesterol) 
and enters the blood circulation system through the 
skin or the lymph. Inactive form of vitamin D (pre-
vitamin D3) is converted into circulating form (25-
hydroxy (25-OH) vitamin D) in liver, then metabolically 
active form (1,25 dihydroxyvitamin D 1-25) is 
synthesized in kidneys [39]. The current literature 
shows that melanin pigments controls vitamin D3 
synthesis [40-41]. Although the serum level of the 
vitamin D does not differ in albinism, genetic variations 
in genes involved in skin pigmentation (EXOC2, TYR, 
 
Figure 2: Vitamin D metabolism and transportation in the body. 
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TYRP1, and DCT) affect the 25(OH)D serum 
concentration [42]. 
Vitamin D not only regulates mineral homeostasis 
(calcium and phosphate) and bone integrity, but also 
affects growth and differentiation of the cells [14]. 
Vitamin D is linked to several dermatological diseases 
such as atopic dermatitis, psoriasis, vitiligo, rosacea, 
skin malignancy because of its regulatory role in 
keratinocyte proliferation [43-49]. Active form of vitamin 
D regulates the balance between T helper 1(Th1) and 
Th2 cells. Calcipotriol (Psorcutan) is a topical form of 
active vitamin D analog used for the treatment of mild 
psoriasis because of its regulatory role in skin 
homeostasis. Vitamin D deficiency and genetic 
variations in vitamin D metabolism disrupt skin 
homeostasis. Thus, vitamin D supplements, topical 
vitamin D analogs and phototherapy are considered to 
be effective and safe methods for treating skin 
diseases. UVB phototherapy can be used in treating 
skin disease (psoriasis, eczema, vitiligo and morfea) 
because of its effects in converting 7-
dehydrocholesterol to pre-vitamin D3 [50].  
When activated vitamin D binds with its 
heterodimeric intracellular receptor protein [vitamin D 
receptor/retinoic X receptor (VDR/RXR)], with the help 
of its co-regulatory proteins, this complex becomes 
capable of binding vitamin D responsive elements 
(VDRE) in specific DNA sequences [38] and then starts 
regulating several cellular metabolisms. This 
stimulation activates the expression of target genes. 
The VDR receptors are located in endothelial, 
intestinal, pancreatic, hemopoietic, cardiac and skeletal 
muscle cells, T and B lymphocytes, macrophages, 
mast cells, NK cells and Tregs [51-54]  
Although vitamin D has effects on epidermopoiesis 
and melanin pigmentation [55]), no significant 
association between serum 25(OH)D level and 
albinism were found[56]. In fact, not only vitamin D 
level in the circulation, but also vitamin D receptor 
polymorphism have been associated with different 
diseases [57-58]. The further studies may show that 
the main reason for the skin disease is the genetic 
variation in vitamin D metabolism, rather than vitamin D 
deficiency. As an example, the association between 
atopic dermatitis (AD) severity and vitamin deficiency is 
contradictory. Serum vitamin D concentrations were not 
significantly related to AD severity in different 
populations [59, 60]. Vitamin D receptor polymorphism 
is associated with AD susceptibility [61-62]. 
Vitamin D and Management of Pregnancy in 
Psoriatic Women 
Recent studies have shown that vitamin D is 
associated with many different diseases, including 
obesity and cancer [63-69]. Vitamin D has effects on in 
vitro fertilization (IVF), insulin resistance (IR), 
hyperandrogenism, endometriosis and polycystic ovary 
syndrome (PCOS) [66, 70-71]. The current literature 
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Figure 3: An overview of the vitamin D action on target genes is presented. 
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discusses the relationship between vitamin D and 
female and male fertility [72-74]. Although Somigliana 
et al. [75] have been speculating on the lack of 
relationship between Serum Levels of 25-
Hydroxyvitamin D and fertility, the prevalence of 
vitamin D deficiency in infertile women was extremely 
high in a German retrospective study [76]. Vitamin D 
deficiency in pregnant women increases the risk of 
gallbladder (GB) stasis [77]. Vitamin D is crucial in 
placental function and fetal growth [78], thus maternal 
vitamin D deficiency affects fetal and neonatal health 
[79, 80]. Hypovitaminosis D is a common problem in 
later stages of pregnancy and their newborns, as a 
result, vitamin D supplementation and sun-bathing is 
important for pregnant women [80, 81]. Fetal growth 
restriction (FGR) is a serious growth condition with high 
morbidity and mortality rate and affects 5% of all 
pregnancies. FGR is referred as poor growth of the 
fetus, hence fetus is smaller than genetically 
determined potential size. Management and prevention 
of the FGR can be achieved by supplementing Vitamin 
D [78]. The recent study has shown that Vdr gene 
ablation has an effect on fetal gene expression, yet 
Wilson et al. [82] have demonstrated that the effect of 
Vdr gene ablation can be tolerated by maternal system 
and has limited effects on placental morphology and 
function. To summarize, vitamin D is important for both 
maternal and fetal health, therefore, maternal supply of 
vitamin D and VDR signaling are essential for a 
successful pregnancy. 
DISCUSSION AND CONCLUSION 
Psoriasis is a disease that does not affect fertility of 
the patients. Symptoms of psoriasis can be noticed in 
early adult life. During pregnancy period severity of the 
psoriasis changes because of hormonal change. Thus, 
effective, affordable and safe treatment is required to 
ensure fetal growth and development. Vitamin D and 
vitamin A derivatives are widely used in psoriasis 
treatment, because both of them are capable of 
regulating gene expression by binding responsive 
elements on the genes. As a result, excessive vitamin 
or derivatives intake triggers up regulation or down 
regulation of the genes and causes fetal abnormalities 
during pregnancy. Thus, dermatologists should inform 
women in reproductive period about the teratogenic 
effects of vitamin A derivatives. Also, dermatologist 
must be careful about vitamin derivates and should 
work closely with obstetric and gynecologist during 
pregnancy. 
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